Mankind Pharma Limited (BOM:543904)

Market Cap	973.34B
Revenue (ttm)	122.07B
Net Income (ttm)	19.91B
Shares Out	n/a
EPS (ttm)	49.20
PE Ratio	48.89
Forward PE	46.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,213
Average Volume	9,128
Open	2,353.00
Previous Close	2,352.40
Day's Range	2,339.75 - 2,370.85
52-Week Range	1,910.10 - 3,050.00
Beta	n/a
RSI	31.26
Earnings Date	Jul 31, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 19,540
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543904

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.12% compared to the previous year's 103.35 billion. Earnings were 19.91 billion, an increase of 4.08%.